CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 4 Open-market sale President sold 700 shares at $55.01 ($38,507)
- 4 Open-market sale EVP and CCO sold 1,120 shares at $53.34 ($59,741)
- 4 Open-market sale EVP & General Counsel sold 678 shares at $53.34 ($36,165)
- 4 Open-market sale EVP and CFO sold 1,016 shares at $53.34 ($54,193)
- 4 Open-market sale President sold 93,077 shares at an average $55.12 ($5,130,031)
- 4 Open-market sale CEO sold 3,484 shares at $53.34 ($185,837)
- 4 Open-market sale President sold 2,728 shares at $53.50 ($145,948)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale EVP & General Counsel sold 8,750 shares at $45.10 ($394,636)
- 4 Open-market sale EVP and CCO sold 1,247 shares at $42.56 ($53,072)
- 4 Open-market sale President sold 1,297 shares at $42.56 ($55,200)
- 4 Open-market sale CEO sold 2,960 shares at $42.56 ($125,978)
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- S-3ASR Offering Registration Statement
- 8-K Event Unregistered share sale · Other events
- 3/A Insider 3/A
- 8-K Event Executive or director change
Page 20 of 70 · 1,382 filings